Mattea Reinisch

11PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical molecular engineering of nucleic acids and proteinsAboriginal and Torres Strait Islander nursing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Nov 03, 2025
Multiomic Factor Analysis for Pathologic Complete Response after Pembrolizumab + Trastuzumab + Pertuzumab in HER2-Enriched Early Breast Cancer: WSG-Keyriched-1 Trial.

Monika Graeser, Oleg Gluz, Peter Schmid

|Mar 21, 2025
Targeting PI3K inhibitor resistance in breast cancer with metabolic drugs.

Niklas Gremke, Isabelle Besong, Alina Stroh

|Sep 19, 2023
RANK Expression as an Independent Predictor for Response to Neoadjuvant Chemotherapy in Luminal-Like Breast Cancer: A Translational Insight from the GeparX Trial.

Theresa Link, Jens-Uwe Blohmer, Wolfgang D Schmitt

|Apr 14, 2023
Prognostic and predictive impact of gene expression in node-positive early breast cancer patients receiving dose-dense versus standard-dose adjuvant chemotherapy.

Mattea Reinisch, Simona Bruzas, Oleg Gluz

|Apr 07, 2023
Identifying breast cancer patients at risk of relapse despite pathological complete response after neoadjuvant therapy.

Jens Huober, Marion van Mackelenbergh, Andreas Schneeweiss

|Mar 30, 2022
Gene signatures in patients with early breast cancer and relapse despite pathologic complete response.

Simona Bruzas, Oleg Gluz, Nadia Harbeck

Pageof 2

Frequent Collaborators

6 joint publications

Sherko Kümmel

3 joint publications

Jens-Uwe Blohmer

2 joint publications

Elisabeth Breit

2 joint publications

Christian Jackisch